Hyloris Pharmaceuticals SA announces the US Food & Drug Administration has set 17 October 2023 as the date by which it expects to respond to the application regarding Maxigesic® IV.
Hyloris Pharmaceuticals SA announces the US Food & Drug Administration has set 17 October 2023 as the date by which it expects to respond to the application regarding Maxigesic® IV.